Surgery Partners stock last traded at USD 14.61 on October 16, 2026, down 1.08 percent

Published on 10/17/2026 at 22:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 848.90 million on June 30, 2026. Surgery Partners stock last traded at USD 14.61 on October 16, 2026, down 1.08 percent on Nasdaq.

Quarterly figures and valuation

Second-quarter revenue reached USD 848.90 million, up 2.70 percent year over year, on June 30, 2026.
Adjusted earnings per share came to USD 0.10 versus a USD 0.06 consensus estimate in the second quarter of 2026.
Surgery Partners stock last traded at USD 14.61 on October 16, 2026 at 4:00 p.m. ET, down 1.08 percent from USD 14.77.
The company had a USD 1.9 billion market capitalization and a negative P/E of 21.17 on October 16, 2026.

SGRY, US86881A1007, Illustration mit AI erstellt.

In the second quarter of 2026, Surgery Partners recorded revenue of USD 848.90 million, an increase of 2.70 percent from the year-earlier period and above the USD 830.03 million consensus estimate, according to MarketBeat on October 13, 2026. The last Nasdaq price was USD 14.61 on October 16, 2026 at 4:00 p.m. ET, down 1.08 percent from USD 14.77.

Earnings beat the revenue estimate

The same report said adjusted earnings per share came to USD 0.10 in the second quarter, ahead of the USD 0.06 consensus estimate. Revenue growth was measured against the second quarter of 2025, while the company reported a negative net margin of 2.63 percent for the period.

The figures point to a mixed quarterly profile: sales exceeded expectations, but profitability remained negative. For investors, the gap between revenue execution and earnings quality is the central operating detail in the latest reported period.

Price position and trading activity

Surgery Partners traded 28.05 percent above its 52-week low of USD 11.41 and 37.67 percent below its 52-week high of USD 23.44 on October 16, 2026. Trading volume was 966,776 shares, equal to 44.80 percent below the average volume of 2,157,615 shares.

The company operates more than 300 locations in 30 states, including ambulatory surgery centers, surgical hospitals, physician practices and urgent care facilities, according to Surgery Partners. That footprint gives the revenue figure a clear operating context across outpatient and related healthcare services.

Valuation at USD 1.9 billion

Surgery Partners had a market capitalization of USD 1.9 billion and a P/E of minus 21.17 on October 16, 2026. The company paid no dividend yield in the quoted period. Its valuation therefore remains tied more closely to a return to positive earnings than to shareholder distributions.

Comparison with peers

Surgery Partners (Nasdaq, USD): minus 1.08 percent, P/E minus 21.17, market capitalization USD 1.9 billion
Tenet Healthcare (NYSE, USD): minus 2.86 percent, P/E 10.31, market capitalization USD 21.5 billion
Select Medical (NYSE, USD): minus 0.09 percent, P/E 15.15, market capitalization USD 2.0 billion

Nasdaq price remains below the high

The stock's last Nasdaq price was USD 14.61 on October 16, 2026 at 4:00 p.m. ET. The level was 37.67 percent below the 52-week high and 28.05 percent above the 52-week low, leaving the current quote closer to the lower end of its annual range.